Matches in Wikidata for { <http://www.wikidata.org/entity/Q88716300> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q88716300 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q88716300 description "scientific article published on 01 May 2018" @default.
- Q88716300 description "wetenschappelijk artikel" @default.
- Q88716300 description "наукова стаття, опублікована в травні 2018" @default.
- Q88716300 name "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 name "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 type Item @default.
- Q88716300 label "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 label "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 prefLabel "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 prefLabel "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 P1433 Q88716300-EFB79A30-1940-468A-B770-967A0DFB0279 @default.
- Q88716300 P1476 Q88716300-EC3F490A-2B0E-48F0-845A-401FBBC9B3AF @default.
- Q88716300 P2093 Q88716300-07BCAF36-4411-45EC-8F33-3AAAC18F0BED @default.
- Q88716300 P2093 Q88716300-3101881D-B582-4ADA-8200-E1ADFBCA2DC5 @default.
- Q88716300 P2093 Q88716300-5801B84B-3C08-4A06-B322-EB91A0475FD8 @default.
- Q88716300 P2093 Q88716300-80FD6975-7006-4C90-ADD6-E9D16823A271 @default.
- Q88716300 P2093 Q88716300-9FE18C6F-4994-4EB2-AE73-A93129974E20 @default.
- Q88716300 P2093 Q88716300-FD5D464A-B30C-428E-B734-28B7E21167AE @default.
- Q88716300 P304 Q88716300-918DDDEC-27CF-44A8-8536-7515AC6B9131 @default.
- Q88716300 P31 Q88716300-146D9C6F-6D4A-44F6-B146-FD0A59618820 @default.
- Q88716300 P356 Q88716300-806C8A2F-BEA9-4C34-9F90-85FB0E4147A7 @default.
- Q88716300 P433 Q88716300-7E3FC002-099A-48AD-96AD-21840F5B6B92 @default.
- Q88716300 P478 Q88716300-6CE318BE-E9CF-46BC-B66C-E0B35E5763B4 @default.
- Q88716300 P577 Q88716300-96E26D3E-01D1-4603-AF85-EE2D942F168F @default.
- Q88716300 P698 Q88716300-DF68ED6D-DE6A-4707-9915-4D7FA2AE7EDF @default.
- Q88716300 P921 Q88716300-5F71A51C-962A-44DF-A4A4-D33A35F5A5D4 @default.
- Q88716300 P356 23258160-20180501-07 @default.
- Q88716300 P698 29772044 @default.
- Q88716300 P1433 Q27724588 @default.
- Q88716300 P1476 "A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD" @default.
- Q88716300 P2093 "Brian B Berger" @default.
- Q88716300 P2093 "Brian D Sippy" @default.
- Q88716300 P2093 "Christine R Gonzales" @default.
- Q88716300 P2093 "Gabriela Burian" @default.
- Q88716300 P2093 "John A Wells" @default.
- Q88716300 P2093 "Victor H Gonzalez" @default.
- Q88716300 P304 "336-345" @default.
- Q88716300 P31 Q13442814 @default.
- Q88716300 P356 "10.3928/23258160-20180501-07" @default.
- Q88716300 P433 "5" @default.
- Q88716300 P478 "49" @default.
- Q88716300 P577 "2018-05-01T00:00:00Z" @default.
- Q88716300 P698 "29772044" @default.
- Q88716300 P921 Q5452194 @default.